Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma
暂无分享,去创建一个
K. Yong | Laura A Percy | I. Khan | N. Rabin | M. Streetly | S. Narat | S. Schey | S. D'Sa | S. Sachchithanantham | S. Moore | S. Atwal | R. Johnston | S. D’Sa | Laura Percy